Zinc Sulfate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09322 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 19 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | pharyngitis | KG + DL |
| 2 | nasal cavity disease | KG + DL |
| 3 | acute laryngopharyngitis | KG + DL |
| 4 | congenital prothrombin deficiency | KG + DL |
| 5 | thrombotic disease | KG + DL |
| 6 | gastroparesis (disease) | KG + DL |
| 7 | faucial diphtheria | KG + DL |
| 8 | cervical disc degenerative disorder | KG + DL |
| 9 | dyspepsia | KG + DL |
| 10 | acne (disease) | KG + DL |
| 11 | paracetamol poisoning | KG + DL |
| 12 | obsolete contact dermatitis caused by poison oak | KG + DL |
| 13 | injury | KG + DL |
| 14 | radiation or chemically induced disorder | KG + DL |
| 15 | florid cemento-osseous dysplasia | KG + DL |
| 16 | perinatal disease | KG + DL |
| 17 | segmental odontomaxillary dysplasia | KG + DL |
| 18 | disease by subcellular system affected | KG + DL |
| 19 | cell proliferation disorder | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.